In English | En español
Questions About Cancer? 1-800-4-CANCER

Osteosarcoma and Malignant Fibrous Histiocytoma of Bone Treatment (PDQ®)

  • Last Modified: 05/02/2014

Page Options

  • Print This Page
  • Print This Document
  • View Entire Document
  • Email This Document

Changes to This Summary (05/02/2014)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Recurrent Osteosarcoma and MFH of Bone

Added text about the EP-ILC-201 (NCT01650090) trial as a treatment option under clinical evaluation.

This summary is written and maintained by the PDQ Pediatric Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ NCI's Comprehensive Cancer Database pages.